Skip to content

Insider · CIK 0002045943

Kristin Abate

officer

Files at KPTI (Karyopharm Therapeutics Inc.). First filing Mar 6, 2025, latest Oct 2, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 11
$0 bought, $15k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

KPTI: Karyopharm Therapeutics Inc.

KPTIOct 9, 2026 · close 0.61

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
15Weak
KPTIsell
Karyopharm Therapeutics Inc.
$450
378 shares
-2%0% from low-92% from high
15Weak
KPTIsell
Karyopharm Therapeutics Inc.
$38
19 shares
-0%-
15Weak
KPTIsell
Karyopharm Therapeutics Inc.
$504
53 shares
-0%+136% from low-12% from high
30Weak
KPTIsell 6
Karyopharm Therapeutics Inc.
$5,260
559 shares
-2%+171% from low-5% from high
23Weak
KPTIsell 2
Karyopharm Therapeutics Inc.
$352
50 shares
-0%+95% from low-32% from high
23Weak
KPTIsell 2
Karyopharm Therapeutics Inc.
$1,579
265 shares
-1%+79% from low-40% from high
15Weak
KPTIsell
Karyopharm Therapeutics Inc.
$2,279
362 shares
-3%+75% from low-58% from high
30Weak
KPTIsell 6
Karyopharm Therapeutics Inc.
$148
23 shares
-0%+77% from low-58% from high
30Weak
KPTIsell 6
Karyopharm Therapeutics Inc.
$81
12 shares
-0%+100% from low-52% from high
23Weak
KPTIsell 2
Karyopharm Therapeutics Inc.
$952
238 shares
-2%+10% from low-74% from high
30Weak
KPTIsell 6
Karyopharm Therapeutics Inc.
$3,592
571 shares
-6%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-378$1.19$45023,40410 d ago
Sep 1, 2026KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-19$2.02$3823,78240 d ago
May 13, 2026KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Common Stock
+121$0.00$023,854May 15, 2026
May 14, 2026KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-53$9.50$50423,801May 15, 2026
Mar 2, 2026KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-559$9.41$5,26022,063Mar 3, 2026
Jan 27, 2026KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Common Stock
+92$0.00$022,672Jan 29, 2026
Jan 28, 2026KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-50$7.03$35222,622Jan 29, 2026
Jan 21, 2026KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-265$5.96$1,57922,580Jan 22, 2026
Oct 15, 2025KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Common Stock
+12,799$0.00$022,845Oct 16, 2025
Oct 1, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-362$6.30$2,27910,046Oct 3, 2025
Sep 12, 2025KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Common Stock
+46$0.00$010,431Sep 16, 2025
Sep 15, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-23$6.43$14810,408Sep 16, 2025
Sep 3, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-12$6.78$819,463Sep 4, 2025
Jul 22, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-238$4.00$9529,475Jul 23, 2025
Mar 4, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-571$6.29$3,5929,713Mar 6, 2025
Feb 28, 2025KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Common Stock
+933$0.00$010,284Mar 4, 2025
Feb 28, 2025KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Stock Option (right to buy)derivative
+1,866$0.00$01,866Mar 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kristin Abate: insider trades and track record | InsiderTell